Dianthus Therapeutics Chief Accounting Officer Edward Carr disposes of shares for $2.01 million
DNTH•Chief accounting officer exercises options and sells shares
Dianthus Therapeutics reported Chief Accounting Officer Edward Carr exercised stock options for 20,000 shares at $17.88 on Sep. 17, 2026.
Carr sold 20,000 shares the same day at weighted-average prices from $100.43 to $104.39.
His directly held common stock position fell to zero following the transactions.
He reported beneficial ownership of 43,818 stock options after the exercise.
